Skip to content
LTLTLT

Drawing based on the label description. No photo yet.

“2.5 mg tablets: yellow round, biconvex, film coated tablets imprinted with 'LT' on one side and plain on other side”

LT pill

Pill with imprint LT is yellow, round, 6 mm and has been identified as Letrozole 2.5 mg. It is used for breast cancer. It is supplied by Nucare Pharmaceuticals,inc.

Letrozole 2.5 mg

Imprint
LT
Strength
2.5 mg
Used for
Breast cancer
Color
Yellow
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Nucare Pharmaceuticals,inc
Drug class
Breast cancer medicine (aromatase inhibitor)
NDC
68071-2167, 16729-034, 68071-2167-4, 68071-5264, 68071-5264-3, 17856-0032, 17856-0032-1, 16729-034-10, 16729-034-15, 16729-034-01, 16729-034-16, 16729-034-17, 16729-034-43, 63629-7819, 63629-7819-1, 63629-7819-2, 63629-7819-3, 63629-7819-4, 50090-3474, 50090-3474-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Letrozole pills and guides

What is Letrozole used for?

Letrozole is used for breast cancer.

Medicine type
Breast cancer medicine (aromatase inhibitor)
Official uses from the US prescribing label

Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Extended Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.

First and Second-Line Treatment of Advanced Breast Cancer

Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. Letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

From the FDA-approved label on DailyMed (published Aug 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows LT and the other side is plain.
  • It is yellow, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Letrozole

Inactive: Silicon Dioxide, Hypromellose 2910 (6 Mpa.s), Ferric Oxide Yellow, Lactose Monohydrate, Magnesium Stearate, Starch, Corn, Cellulose, Microcrystalline, Polyethylene Glycol 400, Sodium Starch Glycolate Type A Potato, Talc, Titanium Dioxide

Also distributed by

Atlantic Biologicals Corp., Accord Healthcare, Inc., Bryant Ranch Prepack, A-S Medication Solutions

Other pills with imprint LT

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Letrozole pills